of at least 4 dysfunctional segments). The exclusion criteria were as follows: recent myocardial infarction (<30 days), left bundle branch block, unstable angina, prosthetic heart valve, other valvular or congenital heart diseases, history of CABG, symptoms of severe heart failure (HF) (New York Heart Association [NYHA] class IV), atrial fibrillation or sinus rhythm with the heart rate at rest exceeding 100 beats/min, and the presence of restrictive filling pattern.
Preoperative and postoperative clinical status was determined according to the criteria of the NYHA and the Canadian Cardiovascular Society (CCS) functional class for HF and angina, respectively.
Forty-two consecutive patients were prospectively enrolled into the study. The time frame for the enrollment was 24 months. Patients were divided into groups according to the type of a scheduled procedure: group 1 -CABG alone (CABGa, n = 6); group 2 -CABG combined with mitral annuloplasty (CABGma, n = 27); and group 3 -CABG combined with mitral valve replacement (CABGmr, n = 9). The eligibility of patients for a particular therapeutic method was determined according to the echocardiographic criteria presented in TAbLE 1. Patients had to meet all criteria to be classified to a given group. Echocardiographic and clinical assessment was performed at discharge, at 1 month, and at 12 months. All patients provided written informed consent. The study was approved by the institutional review board of the Medical University of Warsaw, Poland.
surgery CABG was performed in all patients using cardiopulmonary bypass in moderate hypothermia with crystalloid and blood cardioplegia. The main aim of the surgery was to perform complete coronary revascularization and, in the majority of patients, mitral valvuloplasty.
Ring size was determined after measurement of the height of the anterior leaflet and intertrigonal distance, and then downsizing by 2 sizes (undersizing annuloplasty). 9, 10 The intraoperative criteria of successful surgery were as follows: leaflet coaptation height ≤0.6 cm, tenting area ≤1.2 cm², and FIMR ≤1 grade. Recurrent FIMR was defined as at least moderate insufficiency at follow-up visits in patients with no or small FIMR at discharge.
The echocardiographic criteria of the procedure efficacy during 12-month follow-up included the presence of left ventricular reverse remodeling (LVRR), no FIMR recurrence at follow-up, and no significant increase of FIMR during ExE (effective regurgitation orifice [∆ERO] >13 mm²).
Echocardiographic measurements and calculations
Transthoracic (TTE) and transesophageal (TEE) echocardiograms were performed within 2 to 3 days before surgery, and serial TTE examinations were performed at discharge and at follow-up visits.
severe FIMR. Restrictive annuloplasty combined with CABG is the most common surgical procedure in this patient group. However, the sobering results of the current strategies create the need for better preoperative assessment of mitral valve and left ventricular (LV) geometry and function. 4, 5 There are no straightforward clinical and echocardiographic criteria that would help effectively decide which procedure to choose -mitral valve surgery or CABG alone. A strict correlation between stress-induced changes of FIMR degrees, myocardial viability, mitral deformation indexes (MDI), and clinical symptoms and prognosis in patients should be taken into account when evaluating the eligibility of patients with severe FIMR for a particular surgical treatment. 6-8 Such evaluation could help improve risk stratification and identification of patients who would likely benefit from different surgical strategies. In our opinion, the greater severity of stress-induced FIMR and MDI correlates with greater necessity to perform mitral valve intervention, and the progression from revascularization alone to revascularization with restrictive annuloplasty to revascularization with mitral valve replacement is predicated on the severity of stress-induced MDI and FIMR.
Based on exercise echocardiography (ExE) and dobutamine stress echocardiography (DBX), a diagnostic algorithm for precise determination of the range of surgical interventions has been developed.
The aim of the study was to prospectively assess the proposed diagnostic strategy based on stress echocardiography to determine the eligibility of patients with severe FIMR for an appropriate surgical procedure.
PATIENTs ANd mEThOds study population
The study involved 42 patients with a history of myocardial infarction and eligible for CABG (23 women, 19 men; age 18-75 years). All patients had severe FIMR caused by restrictive systolic leaflet motion (Carpentier's type IIIb) with or without annular dilatation (Carpentier's type I) or both.
The study inclusion criterion was the presence of a significant area of viable myocardium observed during DBX (improvement in wall motion Two-dimensional echocardiography All echocardiographic measurements were performed using the iE 33 system version 4.2-5.0 (Philips, United States), a broadband transducer for TTE of 2.5-3.5 MHz frequency and multiplane probe Omniplane II and III for TEE. The measurements were averaged over 3 cardiac cycles.
Severity of mitral regurgitation was quantified using the proximal isovelocity surface area method. Severe FIMR was defined as calculated ERO ≥20 mm² at rest. 11,12 Wall motion abnormalities were evaluated in accordance with the recommendations of the American Society of Cardiology. The wall motion score index (WMSI) was calculated according to a 17-segment model. 13 The LV volumes and ejection fraction (EF) were assessed by the biapical Simpson disk method. The mitral valve deformation was evaluated by measuring the tenting area (i.e., the area between mitral leaflets and the line of annular plane) and the coaptation height (i.e., the distance between leaflet coaptation and mitral annular plane from the parasternal long-axis view at mid-systole). 14 According to Stellbrink et al., 15 a decrease in LV end-systolic The follow-up ExE was repeated 12 months after surgery.
Clinical endpoints The proposed diagnostic algorithm was evaluated by comparing the results obtained during 12-month follow-up in 3 groups of patients. The results included the functional status (NYHA, CCS); dynamics of changes in selected LV function parameters at rest TTE (end-systolic Abbreviations: CH -coaptation height, DBX -dobutamine echocardiography, EDV -end-diastolic volume, EF -ejection fraction, ERO -effective regurgitant orifice area, exe -exercise echocardiography, ESV -end-systolic volume, LVDS -left ventricular end-systolic dimension, SMA -systolic area of the mitral annulus, TA -tenting area, TRPG -tricuspid regurgitation pressure gradient, WMSI -wall motion score index, others -see TAbLE 1 0.49). In the remaining groups, there was a significant increase in FIMR and TRPG during exercise (TAbLE 3) . During DBX, the normalization of MDI and a significant decrease in FIMR were observed in the CABGa group (P <0.001); in the other groups, moderate/severe FIMR was maintained (P = nonsignificant for both groups). During DBX, in the CABGma and CABGmr groups no significant improvement in MDI was observed compared with the values at rest. Clinical endpoints and outcome Early (<30-day) mortality was 11.9% (n = 5). Four patients (14.8%) died in the CABGma group (low cardiac output in 2 patients and multiorgan failure in 2 patients).
One patient (11.1%) died in the CABGmr group (multiple organ failure). Two patients died during follow-up. All patients in the CABGa group survived the perioperative period and 12-month follow-up. Survival rate at 12 months was 100%, 81.5%, and 77.8% in the CABGa, CABGma, and CABGmr groups, respectively (P = 0.3).
tire study population and for all the subgroups according to the applied therapeutic procedure. For quantitative variables with close to normal distribution sample size, minimal and maximal values, arithmetical mean, and standard deviation (SD) are given. Continuous variables with distribution close to normal are presented as mean and SD while categorical variables as n/N (%). For qualitative variables, absolute and relative numbers are given for particular classes. The significance of the observed differences between the groups was examined using the t test, Wilcoxon test, Cochran-Mantel-Haenszel test, and χ 2 test. All analyses were performed using SAS 9.1 (SAS Institute, Cary, North Carolina, United States) and MedCalc 10.4 (Mariakerke, Belgium). Significance for hypothesis testing was set at the 2-tailed level of 0.05.
REsuLTs baseline characteristics
The preoperative clinical and echocardiographic variables in 3 groups are shown in TAbLEs 2 and 3. The mean logistic EuroSCORE was 12.9 ±8.1 for all groups (P = 0.83). There were no significant differences in demographic and clinical characteristics between the groups. During rest echocardiography, no significant differences in basic parameters were observed. Compared with the CABGa group, significantly higher values of MDI were observed in the CABGma and CABGmr groups. During ExE, no significant differences in workload and exercise EF changes were reported in the subgroups of patients. The CABGa group showed a significant decrease in stress-induced FIMR (P = 0.019) and an insignificant increase in TRPG (P = WMSI, EF, and ESV during subsequent follow-up visits did not reveal significant differences between the analyzed study groups. TAbLE 7 presents a pooled analysis of the changes in FIMR value during follow-up. During preoperative assessment, the mean workload value was of 60 ±20.3 W. No significant differences between the study groups were observed (CABGa vs. CABGma vs. CABGmr: 63.3 ±19.4 vs. 58.9 ±21.6 vs. 61.3 ±18.5 W; P = 0.9, respectively). At 12 months, an increase in the workload value during ExE was observed in all groups, but only in the CABGma group the difference was statistically significant (P <0.001; TAbLE 6). At 12 months, no significant increase in FIMR was observed in any of the subgroups during ExE.
Reverse remodeling At 12 months, LVRR was observed in 83% of the patients in the CABGa group, 63.7% in the CABGma group, and 100% in the CABGmr group. There were no differences between the patient groups (P >0.05). In 2 patients in the CABGma group, the ESV value was significantly increased when compared with
In the whole study group, there were 5 hospitalizations (11.9%) due to HF exacerbation during follow-up (no hospitalizations in the CABGa group; 3 hospitalizations [11.1%] in the CABGma group, and 2 hospitalizations [22.2%] in the CABGmr group).
Postoperative functional status At baseline, the mean values of NYHA and CCS were not significantly different between the study groups (TAbLE 2) . At 12 months, an improvement in CCS and NYHA was noticed in all study groups, but a statistical significance was reported only in the CABGma group (TAbLE 5) . At the final follow-up visit, the majority of patients in all subgroups had NYHA class I and CCS class 1, and we observed no differences between the subgroups with respect to NYHA and CCS classes (P = 0.36 and P = 0.32, respectively).
Echocardiographic results The analysis of selected echocardiographic variables at 12 months showed most beneficial changes in the CABGma group (TAbLE 6). The comparison of the mean values of differences in the NYHA and CCS classes were observed between the groups. Our results are in agreement with those reported by Kim et al., 21 who observed a similar improvement in the NYHA class at 2-year follow-up in the CABG and repair groups. 21 During follow-up, we observed a statistically significant reduction in FIMR in all study groups (TAbLE 6) . Small, moderate, and severe FIMR was observed in 29 (83%), 5 (14%), and 1 (3%) surviving patient, respectively (TAbLE 7) . Complete revascularization performance resulted in a significant improvement in LV geometry and function, particularly in the CABGma group. Kang et al. 22 reported that patients who demonstrated an improvement in LV function and a reduction in LV size after CABG also had a reduction in FIMR degree at 1 year. 22 In our study, we observed a similar reduction in FIMR in the CABGa group (TAbLE 6). The progress of LV remodeling and, secondarily, the posterior mitral valve leaflet restriction are the mechanisms responsible for the lack of improvement or increase in FIMR degree after surgery. 23 In our study, independently of the type of surgery, we observed LVRR in most patients and favorable echocardiography results were reflected in their clinical status.
To our knowledge, this is the first and the largest analysis of the criteria for the selection of patients for surgical treatment based on all the essential components of mitral complex functioning in echocardiography examination at rest and during exercise. However, it was an observational, nonblinded, single-center, prospective case series study, and the application of our results is limited. The main limitation is a relatively low number of patients. Thus, the statistical power of correlations is low. It has to be stressed, however, that severe FIMR in patients treated with CABG is observed only in a small number of patients. Considering the innovative character of this study, our group of patients is one of the most numerous groups presented in the literature, and it is the first study that used such a complex methodology in the selection of patients for surgical procedure.
Another limitation of the study is the lack of randomization, which may result in potential selection bias, possibly leading to incorrect conclusions. It has to be stressed that we used deterministic criteria in the selection of patients for a suitable type of treatment. Lack of randomization resulted in uneven classification of patients to the CABGa, CABGma, or CABGmr groups.
Our results indicate that the use of an elaborate diagnostic strategy based on stress echocardiography may improve decision-making process in the selection of patients with severe FIMR for a suitable surgical procedure, which helps achieve satisfactory clinical results (in the early postoperative period and at 12 months after surgery). Based on such a selection, CABGa may reduce FIMR and lead to functional and structural improvement without an increase in the operative and the baseline value (in both patients recurrence of moderate FIMR was observed; FIGuRE). dIsCussION Currently, restrictive mitral valve annuloplasty is the most widely accepted surgical technique in the management of patients with severe FIMR. The results of this procedure are disappointing due to high rates of persistent and recurrent FIMR at follow-up, which are associated with poor prognosis. 18 The results of current strategies create the need for a better understanding and preoperative assessment of the mitral valve and LV geometry and function.
Selection of patients for CABGa was based on strict echocardiographic criteria (TAbLE 1), the crucial component of which was to reveal the myocardial viability of the LV segments whose dysfunction during rest examination generated severe FIMR. A cumulative analysis of the ExE and DBX results allowed us to make final therapeutic decisions. Simultaneously, it was a prerequisite to obtain complete normalization of MDI and a decrease in FIMR degree during DBX by at least 2 classes. The above criteria allowed us to schedule only 6 patients for this type of treatment. Postoperative results confirmed that our therapeutic decisions were appropriate. Only in this group of patients, there were no deaths or exacerbations of HF or angina symptoms during 12-month follow-up. Additionally, LVRR and only moderate FIMR were observed in the majority of patients in the CABGa group.
In our study, early mortality in the entire study population was 11.9% (n = 5), which is in line with the rates reported in the previous studies in similar high-risk populations.
19,20 The operative mortality was lower in patients who underwent CABGa (0%) than in those who underwent CABGma (14.8%; n = 4) or CABGmr (11.1%; n = 1). During follow-up, only 2 patients died but mortality in the CABGa group was 0%.
The analysis of the functional status and exercise capacity in the follow-up ExE was an important component of the overall assessment of the surgical procedure and its efficacy. At 12 months, the functional status and physical capacity improved in all patients, and no long-term mortality rates in a selected group of patients. Because this novel clinical decision-making tool was applied only in 42 patients, the results should be considered as hypothetical. This must be clearly stated, as should the need to study a larger group of patients before the approach is widely accepted and broadly implemented. Certainly, further validation and randomized studies on a larger patient group and with longer follow-up are needed.
